生命科学资讯

Goldman Sachs Initiates Coverage on Thermo Fisher Scientific (TM - GuruFocus

How Lilly uses Big Pharma heft to lift up-and-coming biotechs

New antibody-drug conjugates disclosed in Genome & Co. patent

Merck Sharp & Dohme discovers new GTPase KRAS degradation inducers

#SABCS25: BioNTech, BMS unwrap Phase 2 data for PD-L1xVEGF-A bispecific in breast cancer

#ASH25: Eli Lilly's Jaypirca makes first-line case, but ceiling may be capped

J&J’s ‘remarkable’ Tecvayli data support earlier use in multiple myeloma

Novartis pens $1.7B immuno-dermatology pact with AI-enabled British biotech

FDA steers cancer CAR-T developers toward randomized superiority trials in policy shift

Zacks.com featured highlights include Illumina, Commercial Metals and Newmont - Yahoo Finance

Zacks.com featured highlights include Illumina, Commercial Metals and Newmont - Nasdaq

Zacks.com featured highlights include Illumina, Commercial Metals and Newmont - Yahoo Finance Singapore

Axa S.A. Lowers Stake in Thermo Fisher Scientific Inc. $TMO - MarketBeat

Goldman Sachs initiates Thermo Fisher Scientific stock with Buy rating - Investing.com

Agilent stock initiated with Buy rating at Goldman Sachs on growth outlook - Investing.com

Thermo Fisher Scientific introduces the Thermo Scientific X and S Series Centrifuges - SelectScience

Is Agilent Technologies Still Priced for Perfection After Recent Share Price Weakness? - simplywall.st

Is Agilent Technologies Still Priced for Perfection After Recent Share Price Weakness? - simplywall.st

ASH: Merck mulls future of polycythemia program while Takeda takes phase 3 victory lap

Glycogen engineering improves the starvation resistance of mesenchymal stem cells and their therapeutic efficacy in pulmonary fibrosis